The researchers used a statistical approach that mimics a randomized clinical trial. They found patients prescribed semaglutide had a significantly lower risk for Alzheimer's disease, compared to ...
The post-marketing study assessed ambulatory blood pressure (ABPM) for eight weeks in patients with overweight or obesity who also had at least one weight-related comorbidity (i.e., hypertension, ...